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Abstract
The role of fibroblast growth factor-2 (FGF-2) in maintaining undifferentiated human embryonic stem cells (hESC) was
investigated using a targeted phosphoproteomics approach to specifically profile tyrosine phosphorylation events
following FGF-2 stimulation. A cumulative total number of 735 unique tyrosine phosphorylation sites on 430 proteins were
identified, by far the largest inventory to date for hESC. Early signaling events in FGF-2 stimulated hESC were quantitatively
monitored using stable isotope dimethyl labeling, resulting in temporal tyrosine phosphorylation profiles of 316 unique
phosphotyrosine peptides originating from 188 proteins. Apart from the rapid activation of all four FGF receptors, trans-
activation of several other receptor tyrosine kinases (RTKs) was observed as well as induced tyrosine phosphorylation of
downstream proteins such as PI3-K, MAPK and several Src family members. Both PI3-K and MAPK have been linked to hESC
maintenance through FGF-2 mediated signaling. The observed activation of the Src kinase family members by FGF-2 and
loss of pluripotent marker expression post Src kinase inhibition may point to the regulation of cytoskeletal and actin
depending processes to maintain undifferentiated hESC.
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Introduction
Human ESCs are a powerful tool for drug screening, studying
early lineage differentiation in vitro, and generating specific cell
phenotypes for therapeutic applications. However, optimizing the
efficient expansion and differentiation of these cells still requires
further understanding, especially of the signaling pathways
responsible for regulating hESC. Several pathways have been
implicated in hESC self-renewal, including transforming growth
factor-b/Activin-A/Nodal [1], sphingosine-1-phosphate/platelet-
derived growth factor (S1P/PDGF) [2], insulin growth factor
(IGF)/insulin [3] and fibroblast growth factor-2 (FGF-2) [4]
(reviewed in Avery et. al. 2006 [5]). The process of self-renewal
appears to be regulated synergistically through various pathways
via growth factor or cytokine supplementation. Interestingly, FGF-
2 signaling appears indispensible to hESC self-renewal just as
leukemia inhibitory factor is to mESC [6]. Therefore, FGF-2 is
widely used for sustained long-term culture of human embryonic
stem cells (hESC) and induced pluripotent stem (iPS) cells under
both feeder and feeder–free culture conditions [7–9].
FGFs execute their biological actions by activating cell surface
fibroblast growth factor receptors (FGFRs) [10,11]. The four
human FGFRs, namely FGFR1, 2, 3 and 4, are members of the
receptor tyrosine kinase (RTK) family. These receptors govern a
wide variety of cellular processes from cell motility and
differentiation to proliferation. hESC express all four FGFR
[4,12–15] whereby blocking of FGFR signaling leads to rapid
differentiation [4,12]. This suggests that FGF-mediated signaling is
important for hESC self-renewal. Following FGF-2 stimulation,
activation of the FGF/FGFRs in hESC typically results in signal
transduction of the FGF canonical pathways, namely the mitogen
activated protein kinase (MAPK) and phosphoinositide 3- kinase
(PI3-K) pathways [4,12,16]. Further downstream signaling events
upon FGF-2 stimulation and its link to hESC self-renewal and the
maintenance of pluripotency remain to be determined.
The large scale analysis of cellular phosphorylation by liquid
chromatography-mass spectrometry (LC-MS) is challenging due to
the low stoichiometry of phosphorylation, causing phosphopep-
tides to remain largely undetected in the overwhelming back-
ground of non-modified peptides. Several of these large scale
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in hESC [17–19]. Although impressive in the number of reported
sites, these latter studies largely failed to monitor tyrosine
phosphorylation. Therefore, specific enrichment of tyrosine
phosphorylated peptides by phosphotyrosine-specific antibodies
may provide a more targeted approach to study tyrosine
phosphorylation [20–22].
To understand the broader implications of FGF signaling in
hESC, we adopted a large-scale, targeted, phosphoproteomics
approach to investigate tyrosine phosphorylation events following
FGF-2 stimulation. Using a peptide-centered immuno-affinity
purification strategy [22,23] 735 unique tyrosine phosphorylation
sites on 430 proteins were detected in two biological hESC
replicates. Combining this enrichment technique with a stable
isotope dimethyl labeling strategy [23,24], a quantitative picture of
the early signaling events in FGF-2 stimulated hESC was
generated. Fig. 1 represents an overview of the quantitative
phosphotyrosine proteomics strategy. Results from our quantita-
tive dataset suggest that all four FGFRs were activated upon FGF-
2 stimulation. Induced tyrosine phosphorylation of members of
both MAPK and PI3-K pathways was also observed. Additionally,
diverse trans-activation of receptors in the EGF family (EGFR,
ERBB2, and ERBB3), Insulin family (IGF1-R and INSR), Ephrin
receptors, and Vascular endothelial growth factor receptor 2
(VEGFR2/KDR) was detected. An increase in phosphorylation of
Src kinase substrates was also observed, suggesting a possible role
of FGF-2 in regulating cytoskeletal and actin dependent processes.
The impact of changes to the cytoskeletal processes on hESC
pluripotency should be further explored.
Results
Effect of FGF-2 stimulation on the hESC
phosphoproteome
To specifically investigate the effects of activating FGFR,
exogenous FGF-2 was added to hESC that were deprived of
FGF-2 for 5 days (1 day , 1 population doubling). Activation of
the hESC was validated by Western blotting using two antibodies
specific for the phosphorylation of proteins downstream of the
FGFR. After 15 min of stimulation, a rapid upregulation of both
phosphorylated ERK1/2 (ph-ERK1/2) and AKT (ph-AKT) was
observed (Fig. S1).
A targeted phosphoproteomics experiment was subsequently
carried out to profile the global tyrosine phosphorylation events
post FGF-2 stimulation using an anti-pY specific antibody to
enrich for tyrosine phosphorylated peptides [22,25]. A total of
6 mg of cell lysate per cell state (different time points following
FGF-2 stimulation) was digested with trypsin and this peptide
digest was subsequently enriched for tyrosine phosphorylated
peptides. The enriched peptides were then analyzed by LC-MS.
A total of 153, 376, 273, 285 and 287 unique tyrosine
phosphorylation sites could be identified respectively from the
0, 1, 5, 15 and 60 min post-FGF-2 stimulated cells. A cumulative
total of 597 unique tyrosine phosphorylation sites were observed.
In a biological replicate performed with similar amounts of
sample and with similar FGF-2 stimulation conditions, a total of
574 tyrosine phosphorylation sites could be identified. Both
experiments led to an overall cumulative 735 unique tyrosine
phosphorylation sites in the two biological replicates (Table S1).
The observed more than double increase in tyrosine phosphor-
ylation immediately after FGF-2 stimulation suggests a prompt
activation of numerous tyrosine phosphorylation signaling
pathways. The 76% overlap we observed between the here
performed biological replicates is much larger than typically
observed in shotgun LC-MS approaches focusing on global serine
and threonine phosphorylation [26]. This is likely caused by the
significant reduction in sample complexity after enrichment of
tyrosine phosphorylated peptides, thus allowing a more compre-
hensive and reproducible profiling of tyrosine phosphorylation
[22]. A first classification using Panther [27] indicated that many
of the detected pY sites were on proteins involved in (growth
factor) signaling, such as the expected FGFs, but also EGF,
Figure 1. Overview of the quantitative proteomics workflow.
Samples are stimulated for different times with FGF-2 followed by lysis
and digestion. The peptides are differentially labeled by stable isotope
dimethyl labeling and combined followed by simultaneous enrichment
of tyrosine phosphorylated peptides using a phosphotyrosine specific
antibody. The enriched fraction is analyzed by LC-MS.
doi:10.1371/journal.pone.0017538.g001
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pathways.
A comparison of our hESC dataset with known pY site locations
obtained from Phospho.ELM (version 8.2) and Rikova et al. [25]
yielded overlaps of only 23% and 41%, respectively (Fig. S2). A
global motif analysis was performed on the residues adjoining the
phosphorylation sites in our hESC dataset. Overrepresented
sequence motifs were extracted using Motif-X [28]. Employing
the human IPI database for background sequences, 7 significant
motif patterns could be identified, covering over 53% of our
dataset (Fig. 2A–B). Comparison of the seven motif patterns
identified in hESC with both the phospho.ELM database and the
Rikova data revealed that motif 1 and motif 5 are unique to our
hESC dataset. Amongst the proteins exhibiting such motifs were
PI3-K (in motif 1), MAPK1, MAPK3, GAB1, SHB, ERBB3,
TJP1, PKP2, PKP4, and CDK5 (all in motif 5) (Table S2). Further
comparison to the Human Protein Reference Database [28]
confirmed that both motif 1 and motif 5 are indeed unique to our
cumulative hESC dataset (Fig. 2C).
Quantitative phosphoproteomics
In order to accurately quantify the tyrosine phosphorylation
events, we next applied a combined approach of pY-peptide
immunoprecipitation (IP) and stable isotope labeling. Using this
combined approach, we have generated a more precise and
quantifiable tyrosine phosphorylation profiles [22]. Our Western
blot results on ERK1/2 and AKT (Fig. S1) indicated that most of
the tyrosine phosphorylation events occur within 15 min of FGF-2
stimulation. Therefore, 0, 5 and 15 min post FGF-2 stimulation
time points were chosen for this profiling study. hESC lysate for
each time point (6 mg) was digested, followed by stable isotope
dimethyl labeling, whereby the non-stimulated hESC (0 min) was
labeled with light dimethyl labels, the 5 min time point with
intermediate labels, and the 15 min time point with heavy
dimethyl labels. The differentially labeled samples were mixed
1:1:1 and enriched simultaneously for pY peptides by IP. The
enriched pY peptides were then analyzed by LC-MS, using a 3 h
elution gradient. By comparing their signal intensities, peptides
from the different FGF-2 stimulated time points could be relatively
quantified. From our analysis, 316 unique pY-peptide triplets
(light, intermediate, heavy) with 300 unique tyrosine phosphory-
lation sites were identified (Table S3). The quantitative analysis
demonstrated an increase in tyrosine phosphorylation of all 4
FGFRs and some of their canonical downstream effectors (eg.
PLC-W, MAPK, PI3-K) following FGF-2 stimulation Fig. 3.
Furthermore, a large number of pY-peptides not directly involved
in the canonical FGF pathway were also identified with increased
phosphorylation upon FGF-2 stimulation. These include Src
kinase substrates (e.g. FAK, CTTN, PXN, SHANK2), additional
receptor tyrosine kinases (e.g. INSR, IGF1R, KDR, ERBB2,
MEGF-10), and many others (e.g. Occludin, TJP1, TJP2, Kirrel)
(Fig. 3). To classify the global response to FGF-2, a cluster analysis
was performed based on the temporal tyrosine phosphorylation
profiles. Phosphopeptides that showed at least a 2-fold increase
(arbitrarily chosen as a substantial increase) in tyrosine phosphor-
ylation at either of the stimulated time points (5 min or 15 min)
Figure 2. Tyrosine phosphorylation motifs overrepresented in the hESC cumulative dataset. Seven motifs were found to be significantly
overrepresented using the Motif-X algorithm. (A) Distribution of different motifs in the dataset. For approximately half of the phospho-peptides (53%)
an overrepresented motif could be identified, with the most abundant motifs being motifs 3 (12%) and 4 (11%). (B) Sequence logos of the various
motifs. (C) Comparison of motifs among the various datasets. The table shows the motifs found in the different datasets, and their respective motif
score. Motifs 2, 3, 4, 6, and 7 were also found either in the Phospho.ELM (ver. 8.2) or the Rikova et.al [25] datasets. Motifs 1 and 5, however, are unique
to the hESC dataset. The number of foreground matches, background matches and the level of fold increase for each motif are also shown in the
table.
doi:10.1371/journal.pone.0017538.g002
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of the pY phosphopeptides (approximately 34.5%) showed
sustained or transient activation (Clusters 3 and 4) upon
stimulation. The pY peptides of all FGFRs and some of their
downstream targets (PLC--W, MAPK1, MAPK3, PI3-K, SHC)
were found within these clusters.
Interestingly, various substrates of the Src kinase family were also
found within these clusters, namely Shank2, F11R, PKP2, TJP2,
CDK5 (all in cluster 3), and CTTN, OCLN, FAK, PKP3, PXN,
and TJP1 (all in cluster 4) (see Table S4). The Src family kinases
have been implicated in the maintenance of stem cell pluripoten-
cy[29]. Selective inhibition of these kinases by the chemical
inhibitor SU6656 resulted in the downregulation of expression of
such pluripotent marker as Oct3/4 and Nanog and decreased
growth of hESCs[29]. Similar results were also observed in our
study (Fig. S3A–C). Despite the continuous stimulation of hESC
with FGF-2, inhibition of Src kinases with 1 mM SU6656 for 6 days
led to significant downregulation of Oct3/4, Nanog and EpCAM
expression, suggesting the importance of Src kinase signaling in
maintaining the undifferentiated hESC phenotype. Concomitantly,
decrease incellnumbers was observed followingSU6656treatment,
however, this was more pronounced at 4 mM (Fig. S3B).
To confirm theincreased phosphorylation of the RTKs identified
post FGF-2 stimulation, a protein array containing 42 different
human RTKs (includingreceptors from the FGF, EGF, VEGF,and
insulin receptor families) was used (Fig. 5). In the array experiment,
we also included an additional time point (60 min) to understand
thepatternofphosphorylationinstimulatedhESC.Arapidincrease
in phosphorylation of all FGF receptors was observed (Fig. 5A–B).
Furthermore, phosphorylation levels for INSR, IGF1-R, EphA 1
and 2, VEGFR2/KDR were also increased as compared to the
basal level (no stimulation). (Fig. 5C–F). Results from the array
confirmed an elevated level of phosphorylationin several RTK, and
all four FGFRs (FGFR1–4) were activated simultaneously upon
FGF-2 treatment.
Discussion
Many cytokines and growth factors have been shown to play a
role in maintaining self-renewal of hESCs (reviewed in [5,30]).
The central role of FGF-2 in maintaining hESC self-renewal
remains undisputable, as almost all hESC culture platforms
require FGF-2 supplementation. Withdrawal of exogenous FGF-2
from hESC results in the loss of pluripotent marker expression
(Oct-3/4, Tra-1-60, and Podocalyxin) [12]. Furthermore, blocking
FGFR signaling in hESC leads to rapid differentiation [4,12].
Interestingly, co-localization of all four FGFRs occurs on Oct-3/4
positive cells. Taken together, these results suggest that FGF-
mediated signaling is important for the maintenance of the
undifferentiated hESC phenotype. To further understand FGF-2
mediated FGFR signaling in hESC, we profiled tyrosine
phosphorylation events following FGF-2 stimulation.
The main challenge in tyrosine phosphoproteomics is the low
abundance of tyrosine phosphorylated proteins. In this study, we
Figure 3. Quantitative temporal profiles of site-specific tyrosine phosphorylation upon FGF-2 stimulation for a selection of
proteins. Data is normalized to no FGF-2 stimulation (0 min, dashed line).
doi:10.1371/journal.pone.0017538.g003
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peptides from large quantities of complex samples. Using this
approach, 735 unique tyrosine phosphorylation sites in the two
biological replicates were identified. To our knowledge, this is to
date the largest tyrosine phosphorylation dataset reported for a
hESC phosphoproteome. The overlap of our cumulative dataset
with the datasets from Phospho.ELM and Rikova et. al. [25] is
23% and 41% respectively. Dissimilar cell constitutions (human/
mouse cell lines/tissues for phosho.ELM, lung cancer cell lines/
tissues from Rikova) together with different enrichment strategies
could account for this difference. It has been estimated that
tyrosine phosphorylation accounts for about 1% of all phosphor-
ylated events in human cells [31], hinting at potentially over
,75,000 phosphorylation events in our hESC. This is still an
order of magnitude higher than currently achievable in large-scale
phosphoproteomics screens [17,32].
We identified, using Motif-X [33], a total of 7 tyrosine
phosphorylated sequence motif. Interestingly, motif 1 and motif
5 have not been previously reported in any pY dataset, and could
be specifically enriched in hESC. The hESC unique motif 5 has an
arginine residue at the P+3 position, and was detected on proteins
including MAPK1, MAPK3, GAB1, SHB, ERBB3, TJP1, PKP2,
PKP4, and CDK5. Motif 1 contains a glutamic acid residue at P-
2, and an alanine residue at P+1 position. A phosphopeptide of the
regulatory subunit of PI3-K has a peptide sequence that belongs to
motif 1, which is of interest as the PI3-K signaling pathway has
been reported to be important for hESC self-renewal [12,34]. The
position of the glutamic acid at P-2 was also observed in motif 4.
Figure 4. Clustering of temporal tyrosine phosphorylation profiles in response to FGF-2 stimulation. (A) The clusters. The grey lines
show the profiles of the individual peptides within that cluster. The shapes that define the characteristics of each cluster are shown as thick red lines
in the graph. (B) The qualitative description of each cluster and the number of peptides. The 174 peptides that display less than 2-fold change in
activity are excluded from the clustering and are instead grouped into cluster 6 (no significant activity).
doi:10.1371/journal.pone.0017538.g004
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kinase has been proposed to be the upstream kinase recognizing
motif 4 [33]. The close resemblance between motifs 1 and 4 may
imply that proteins/peptides belonging to motif 1 are also
phosphorylated by Src kinases.
Quantitative profiling of tyrosine phosphorylation
In order to understand early key signaling events of FGF-2
stimulated hESC, it is important to study the temporal
involvement of the FGFRs, other RTKs, and their subsequent
substrates post FGF-2 stimulation. Results from Western blotting
of FGF signaling downstream effectors (ph-ERK1/2 and ph-AKT)
demonstrated rapid response (5–15 min) of these downstream
effectors to FGF-2 stimulation, hence we selected 0, 5, and 15 min
for a more in-depth quantitative study. Stable isotope dimethyl
labeling method was selected to be used in conjunction with pY-
peptide IP. By performing stable isotope labeling prior to IP,
potential variation in the IP or LC-MS step is mitigated as sample
handling and analysis is performed simultaneously for all samples.
A potential downside is that up to 6 mg of material needs to be
isotope labeled, necessitating a cost-effective labeling approach
provided by reductive dimethyl labeling. Using the above
combination, 316 unique quantifiable tyrosine phosphorylated
peptides, occurring as a triplet in the MS data, could be identified
and quantified.
As expected, increased tyrosine phosphorylation at multiple sites
of FGFRs was observed after FGF-2 stimulation, notably on all
four FGFRs. The use of the RTK array confirmed the
simultaneous activation of the four FGFRs. A separate study by
Livia et. al (2004) [35] using the RTK array also demonstrated
activation of FGFRs in hESC by FGF-2 stimulation. Increases in
tyrosine phosphorylation of downstream targets implied in
canonical FGF signaling, such as PLC–W, GAB1, MAPK1/3,
PI3-K could also be detected. The temporal response of pY
residues at the autophosphorylation sites on the FGFRs indicates
propagation of the signal due to the presence of exogenous FGF-2.
Apart from FGFRs, several other receptors were found to be
rapidly tyrosine phosphorylated following FGF-2 stimulation.
Figure 5. Human phospho-RTK array to detect proteins activated upon FGF-2 stimulation. (A, B) Phosphorylation levels of FGFR 1, 2, 3,
and 4 are increased upon FGF-2 stimulation. (C, D, E) Proteins in the insulin receptor, ephrin A, and VEGFR family show an increase in phosphorylation
upon FGF-2. All densitometry results were normalized to cells that had no FGF-2 stimulation (0 min).
doi:10.1371/journal.pone.0017538.g005
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EphB3 and 4, VEGFR2/KDR, and MEGF10. The activation of
most of these receptors was confirmed by a human phospho-RTK
array. IGF1-R and IR have been shown to play a role in self-
renewal of hESC [3,36]. Furthermore, tyrosine phosphorylation of
ERBB2, ERBB3, VEGFR2/KDR, FGFR3, and FGFR4 has been
demonstrated previously upon stimulation with conditioned
medium supplemented with FGF-2 [36]. MEGF10 showed a
noteworthy increase in tyrosine phosphorylation at multiple sites.
There are very limited reports on MEGF10 and its function in
hESC remains to be further explored (see Text S1 for further
discussion). Although many of the results obtained in the pY-IP
approach could be validated using the human phospho-RTK
array, the sequencing approach of the phosphoproteomics method
allows the determination of exactly which tyrosine sites are
differentially phosphorylated and therefore provide higher resolu-
tion data.
One possible explanation for the induced tyrosine phosphory-
lation of other RTKs following FGF-2 stimulation could be
transactivation [37,38]. For example, FGFR1 has been shown to
be capable of tyrosine phosphorylating EphA4 in an adult kinase-
negative mutant cell line [37]. Also, it has been demonstrated that
a transactivation mechanism might even be required to establish
certain physiological processes [38]. The elucidation of these RTK
transactivations and cross-talk between different pathways, once
again, illustrates that a linear view of signal transduction is an
oversimplification of the actual signaling process [18]. Some
RTKs share several of the same downstream targets, including the
above mentioned PLC–W, GAB1, MAPK1/3, and PI3-K, which
may complicate the determination whether phosphorylation of
any of these proteins is the direct result of upstream activation of
FGFR or any of the other RTKs. Therefore, a more comprehen-
sive view based on the data provided here is required to
deconvolute the complex interplay of signaling pathways under-
lying the effect of cellular stimuli.
Src family kinases and substrates
Src family kinases (SFKs) represent a group of tyrosine kinases
that are strongly activated by, amongst others, RTKs [39]. Several
tyrosine phosphorylation sites were identified on members of
SFKs, but the extensive homology, in particular, in the activation
loop of different members of the family complicates the
determination of the exact family member. Interestingly, although
only relatively small increases in tyrosine phosphorylation were
observed for the SFK members, larger increases in tyrosine
phosphorylation were observed for Src substrates, for example,
focal adhesion kinase (FAK). Src and FAK are known to form a
tight complex after activation by RTKs or integrins [40,41]. Src
binds to phosphorylated FAK and promotes further phosphory-
lation of tyrosine residues on FAK.
Cortactin has long been known to be a very efficient substrate
for SFKs and was found in our screen to exhibit increased tyrosine
phosphorylation levels. These phosphorylation events are sup-
posed to create docking sites for proteins containing the SH2
phosphotyrosine binding domain, such as Src family kinases
themselves or adaptor proteins [42,43]. These interactions have
been proposed to influence actin polymerization and thus the
turnover of actin networks. SHANK2 was also found to be heavily
phosphorylated upon induction with FGF. It is a large scaffold
protein associated with actin, and also a binding partner of
Cortactin [44]. Another protein that showed increased tyrosine
phosphorylation is the scaffold protein Paxillin, which localizes at
the sites of cell adhesions. Together with a large number of
interaction partners, Paxillin is heavily involved in cytoskeletal
reorganization and cell adhesion [45–48].
Plakophilin-3, Plakophilin-4, Catenin delta-1, F11R, Occludin,
KIRREL/Neph1, TJP-1 and TJP-2 are found in tight junctions
and an increased tyrosine phosphorylation was detected in our
screen. Of these proteins Catenin delta-1, Occludin, TJP-1 and
TJP-2 have been described as genuine Src kinase substrates; the
phosphorylation of the aforementioned sites has been shown to
modulate the regulation of cell-cell adhesions as well as the
formation of tight junctions [45,49,50].
The prevalence of activity of Src family kinases can be seen
from both Motif mapping (Motif 1 and 4) and the large number of
Src kinase substrates identified. SFKs can also be recruited by
receptor mediated phosphorylation and influence the signaling
dynamics of the cell. It has been stated that Src activity controls
FGFR activation and FGF-2 induced AKT activation is
dependent on activation of Src [51]. Furthermore, SFKs are
known to promote cell growth and survival by activation of MAP
kinase pathways (e.g. MEKK2/5, Erk5) or the signal transducers
and activators of transcription (STAT) family (e.g. STAT3). In this
study, we demonstrate that Src kinase activity is crucial for the
maintenance of pluripotency by FGF-2. Inhibition of Src kinases
resulted in decreased growth and expression of markers repre-
senting the undifferentiated hESC state. Results from this
investigation and previous study by Annaren et. al. (2004) suggest
a considerable involvement of these kinases and their substrates in
hESC in maintenance of undifferentiated hESC[29].
Other interesting targets
CDK5 was also found to be upregulated upon FGF-2
treatment. CDK5 is an atypical member of the cyclin dependent
kinase family, which has rather been found to be involved in the
regulation of CNS development [52]. Many of its substrates are
also involved in cytoskeletal regulation and neuronal migration
such as c-Abl, Src, PAK1 or b-catenin.
Multiple EGF-like domains 10 (MEGF10) was identified in the
dataset with an average of 5 fold-change on all the four pY-
peptides identified (within 5 min of FGF-2 stimulation). Out of the
four pY-peptides identified, two were not reported previously.
Additionally, this is the first account for identification of tyrosine
phosphorylation of MEGF10 in hESC, but its precise function in
hESC is largely unknown. MEGF10 is believed to be the
mammalian ortholog of nematode CED-1, a cell surface receptor
involved in phagocytosis of dead cells [53,54]. It has been known
to interact with clathrin assembly protein complex 2 medium
chain (AP50) [55], and ATP binding cassette transporter (ABCA1)
[54]. The function of this protein is largely thought to be involved
in cell engulfment due to its similarity with CED-1 [54,55]. It has
also been reported to have a role in novel adhesion pattern,
restricting cell motility, and inducing large vacuole formation
[53,55]. There are limited reports on the MEGF10 signaling
pathway. Whether the function of the protein is supporting self-
renewal of hESC remains to be elucidated.
Conclusion
In this study, we have provided a global temporal tyrosine
phosphorylation profile of hESC after FGF-2 stimulation. In
Figure 6, the events following the introduction of FGF-2 to hESC
are summarized. Remarkably, we did not only observed an
activation of the FGFR pathways, but also detected the tyrosine
phosphorylation of several other RTKs upon FGF-2 stimulation.
This activation could be either a direct effect of FGF-2 (although
no specificity for FGF-2 is known for the mentioned RTKs),
through transactivation, which would involved an FGFR, or via a
Tyrosine Phosphorylation Profiling in hESC
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downstream target substrates that are tyrosine phosphorylated.
Not surprisingly, we found a plethora of proteins with increased
levels of tyrosine phosphorylation upon FGF-2 stimulation, many
of which have not been associated with FGF signaling before.
Many of these proteins have been described as integral
components and also key players in the aforementioned processes
in adult cells with functions including modulation of cell-adhesion,
cell-cell interaction, migration and the formation of tight junctions.
Our preliminary results from our Src kinase inhibition experiment
suggest possible involvement of the Src kinase and its substrate in
the maintenance of undifferentiated hESC phenotype. Interest-
ingly, changes to cytoskeletal and actin dependent processes are
major events during hESC differentiation [56]. Therefore, we
hypothesize that the pluripotency maintaining effect of FGF-2 in
hESC might be partially executed through these processes.
Materials and Methods
Cell culture, stimulation, and cell lysis
Human ESC line, HES-3 (46 X,X) was obtained from ES Cell
International (ESI, Singapore). Briefly, the cells were cultured on
Matrigel-coated (Becton, Dickinson and Company, Franklin
Lakes, NJ) tissue culture dishes and supplemented with condi-
tioned medium from MEF. For routine culture, the medium was
supplemented with 10 ng/ml of FGF-2 (Invitrogen, Carlsbad, CA,
USA), and medium was changed daily. The cultures were
passaged weekly following enzymatic treatment as previously
described [57]. For FGF-2 starved cultures, cells were maintained
in the absence of FGF-2 for 5–7 population doublings (PD, 1 PD
= ,1 day). Cells were then stimulated with 10 ng/ml of FGF-2 at
the indicated time points.
Cells were lysed on ice in 7 M urea, 2 M thiourea, 4% CHAPS,
40 mM Tris, 50 mg/ml DNase, 50 mg/ml RNase, 1 mM sodium
orthovanadate and 1X PhosSTOP (Roche Diagnostics, Switzer-
land, Rotkreuz, http://www.roche.com/) in the presence of
protease inhibitors. Protein concentration was determined using
Bradford Assay. Total protein lysate of 6 mg per time point were
reduced with dithiothreitol (DTT) at a final concentration of
10 mM at 56uC. Subsequently, lysates were alkylated with 55 mM
iodoacetamide. Lysates were diluted 6-fold with 100 mM
ammonium bicarbonate and digested overnight with trypsin.
Stable isotope labeling by reductive dimethylation of
tryptic peptides
Tryptic peptides were desalted using a Sep-Pak C18 column
(Waters, USA, Massachusetts), eluted peptides were lyophilized,
and re-suspended in 100 mL of triethylammonium bicarbonate
(100 mM). Subsequently, stable isotope dimethyl labeling was
performed on the full digested lysate (,6 mg) as described before
[22] using formaldehyde-H2 and cyanoborohydride, formalde-
hyde-D2 and cyanoborohydride and formaldehyde-
13C–D2 and
cyanoborodeuteride to generate light, intermediate and heavy
dimethyl labels, respectively. The light, intermediate and heavy
dimethyl labeled samples were mixed in 1:1:1 ratio based on total
peptide amount, determined by analyzing an aliquot of the labeled
samples on a regular LC-MS run and comparing overall peptide
signal intensities.
Immunoprecipitation (IP) of phosphopeptides
Prior to LC-MS analysis, the differentially labeled peptides from
the three different digested lysates were mixed, desalted with Sep-
Pak C18 column, and lypholized. Labeled peptide mixtures were
dissolved in IP buffer containing 50 mM Tris (pH 7.4), 150 mM
NaCl, 1% NOG, and 1x complete mini protease inhibitor cocktail
(Roche diagnostics). Agarose-conjugated anti-p-Tyr (pY99) anti-
bodies (Santa Cruz Biotechnology Inc., USA, CA) (prewashed
three times with IP buffer) were added into each peptide mixture
and incubated overnight at 4uC with gentle rotation. After
incubation, the beads were then washed three times with 1 ml of
IP buffer followed by two times with 1 ml of water, all at 4uC.
Figure 6. Summary of tyrosine phosphorylated RTKs and its downstream targets after FGF-2 stimulation in hESC culture. FGF-2
treatment of hESC results in the activation of all four FGFR family members as well as possibly transactivation of members of several other receptor
families such as the insulin receptor family, the Ephrin type A family and the KDR receptor. Increased tyrosine phosphorylation was found on
downstream substrate targets of these RTKs including Src kinase substrates.
doi:10.1371/journal.pone.0017538.g006
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for 1 min to separate the antibody beads from the eluate. Eluted
peptides were desalted and concentrated on STAGE-tips.
On-line nanoflow LC-MS
Nanoflow LC-MS/MS was performed by coupling an Agilent
1100 HPLC system (Agilent Technologies, Waldbronn, Germany)
to a LTQ-Orbitrap mass spectrometer (Thermo Electron, Bremen,
Germany) as described previously [58]. Dried fractions were
reconstituted in 10 mL 0.1 M acetic acid and delivered to a trap
column (Aqua
tm C18, 5 mm, (Phenomenex, Torrance, CA, USA);
20 mm 6 100 mm ID, packed in-house) at 5 mL/min in 100%
solvent A (0.1 M acetic acid in water). Subsequently, peptides were
transferred to an analytical column (ReproSil-Pur C18-AQ, 3 mm,
Dr. Maisch GmbH, Ammerbuch, Germany; 40 cm 650 mmI D ,
packed in-house) at ,100 nL/min in a 2 hour (non-labeled) or
3 hour (stable isotope dimethyl labeled) gradient from 0 to 40%
solvent B (0.1 M acetic acid in 8/2 (v/v) acetonitrile/water). The
eluent was sprayed via distal coated emitter tips (New Objective),
butt-connectedtotheanalyticalcolumn.The massspectrometer was
operated in data dependent mode, automatically switching between
MS and MS/MS. Full scan MS spectra (from m/z 300–1500) were
acquired inthe Orbitrap with a resolution of 60,000 at m/z 400 after
accumulation to target value of500,000. The three mostintense ions
at a threshold above 5000 were selected for collision-induced
fragmentation in the linear ion trap at normalized collision energy of
35% after accumulation to a target value of 10,000.
Data analysis
All MS
2 spectra were converted to single DTA files using
Bioworks 3.3 at default settings. Runs were searched using an in-
house licensed MASCOT search engine (Mascot version 2.1.0)
software platform (Matrix Science, London, UK) against the
Human IPI database version 3.36 (labeled sample; 63012
sequences) or version 3.37 (non-labeled sample; 69164 sequences)
with carbamidomethyl cysteine as a fixed modification. Light,
intermediate and heavy dimethylation of peptide N-termini and
lysine residues (for labeled samples only), oxidized methionine and
phosphorylation of tyrosine, serine and threonine were set as
variable modifications. Trypsin was specified as the proteolytic
enzyme and up to two missed cleavages were allowed. The mass
tolerance of the precursor ion was set to 5 ppm and for fragment
ions 0.6 Da. Peptides were assigned to the first protein hit reported
by Mascot. The assignment of phosphorylation sites of identified
phosphopeptides was performed by the PTM scoring algorithm
implemented in MSQuant as described previously [31]. Individual
MS/MS spectra from phosphopeptides were accepted for a Mascot
score $20 [22]. The FDR at this score was estimated to be less than
3.5% (and less than 1% for tyrosine phosphorylated peptides only)
by performing a concatenated decoy database search [22]. All
identified phosphopeptides that were found to be differentially
phosphorylated were manually validated as previously de-
scribed[59]. The quality of the spectrum was judged based on a
sufficient number of b- and/or y-ions –preferably those that contain
the pY residue- to consolidate the peptide sequence. Furthermore,
no dominant neutral loss of phosphoric acid should be observed
when no additional serine or threonine phosphorylation was
annotated to assure phosphorylation of a tyrosine residue.
Quantification
Quantification of peptide triplets of which at least one has
obtained a Mascot peptide score of 20 was performed using an in-
house dimethyl-adapted version of MSQuant [60], as described
previously [22,23]. Briefly, peptide ratios were obtained by
calculating the extracted ion chromatograms (XIC) of the ‘‘light’’,
‘‘intermediate’’ and ‘‘heavy’’ forms of the peptide using the
monoisotopic peaks only. The total XIC for each of the peptide
forms was obtained by summing the XIC in consecutive MS cycles
for the duration of their respective LC-MS peaks in the total ion
chromatogram using FT-MS scans. This total XIC was then used
to compute the peptide ratio. Quantified proteins were normalized
against the Log2 of the median of all peptides quantified.
StatQuant, an in-house developed program [61], was used for
normalization, outlier detection and determination of standard
deviation. Ratios of phosphotyrosine levels were normalized to the
ratios of (non-specifically binding) non-phosphorylated peptides.
Western Blotting
Cells were lysed in 1X Cell Lysis Buffer (Cell Signaling
Technology, Beverly MA, USA) supplemented with 1 mM
phenylmethylsulphonyl fluoride (PMSF). Protein concentrations
were determined using the DC protein assay (Bio-Rad laboratories
Inc., Hercules CA, USA). Twenty micrograms of each sample was
mixed with Laemmli buffer and boiled for 5 min at 95uC. All
samples were subjected to SDS-PAGE and electro-transferred
onto PDVF membranes (0.2 mm, Bio-Rad). Membranes were
probed using the corresponding primary antibodies at the
indicated dilutions. After incubation with the primary antibodies,
appropriate peroxidase-conjugated secondary antibodies (Dako,
Denmark) or fluorescent secondary antibodies (LI-COR Biosci-
ences) were used to detect the bound antibodies. Protein bands
were visualized either using a chemiluminescence detection
reagent ECL Plus (Amersham, GE Healthcare, UK) or LI-COR
ODYSSY imaging system (LI-COR Biosciences, Nebraska). All
antibodies used are shown in Table S5.
Human phospho-receptor tyrosine kinase array
Analysis of protein expression using the human phospho-RTK
antibody array (R&D Systems Inc., Minneapolis) was performed
according to manufacturer’s instructions. Briefly, capture and
control antibodies were spotted in duplicates on nitrocellulose
membranes and incubated overnight with 300 mg protein lysate.
The membrane was then washed extensively with buffer provided
and, further incubated with pan anti-phospho-tyrosine antibody
conjugated to horseradish peroxidase (HRP). After incubation,
arrays were washed and visualized using chemiluminescence ECL
Plus (Amersham).
Dataset Comparison
The hESC phosphoproteome was compared to other datasets by
mapping known pY site locations obtained from Phospho.ELM
(version 8.2) and Rikova et. al.[ 2 5 ] .U s i n gt h eI P Ih u m a nd a t a b a s e ,
1382 and 4117unique pYsiteswere mappedout fromphospho.ELM
and Rikova et. al. datasets respectively. Overlap was determined by
counting the number of identical sites between the datasets.
Supporting Information
Figure S1 Activation of FGF-signaling in hESC. Activation
profile of HES-3 cells post-FGF-2 induction, by Western Blotting.
Cells were starved of FGF-2 for 5 days and 10 ng/ml of FGF-2
was added at the indicated time.
(TIF)
Figure S2 Comparison of hESC cumulative tyrosine
phosphorylated dataset. Overlap of identified phosphotyr-
osine sites between our dataset (hESC), those deposited in
Phospho.ELM (ver. 8.2), and those identified in Rikova et. al.
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PLoS ONE | www.plosone.org 9 March 2011 | Volume 6 | Issue 3 | e17538[25]. Of the 735 phospho-peptides identified in FGF-2 stimulated
hESCs, 374 (50.9%) peptides are unique to our dataset.
(TIF)
Figure S3 Effect of Src Kinase inhibitor on undifferen-
tiated hESC. Cells were treated with increase concentrations of
Src Kinase inhibitor (SU6656) for 6 PD. (A) Morphology of hESC
after treatment with SU6656. Cells treated with 4 mM of SU6656
showed significant reduce in cell number when compared to
control (untreated hESC) Scale bar = 500 mm and 100 mm
respectively (B) Cell count of SU6656 treated hESC. (C)
Pluripotent marker expression of SU6656 treated hESC using
quantitative real time PCR. Data were expressed as mean + SEM
and results were from triplicate runs.
(TIF)
Table S1 Summary of antibodies used.
(PDF)
Table S2 List of cumulative phosphopeptides detected
from FGF-2 stimulated hESC.
(PDF)
Table S3 Motif assignment for phosphopeptides from
the cumulative dataset.
(PDF)
Table S4 List of phosphopeptides from the quantitated
dataset.
(PDF)
Table S5 List of phosphopeptides classified into 5
clusters using cluster analysis.
(TIF)
Text S1 Supplementary Materials and Methods.
(DOC)
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